Table 1.
Study (Publication Year) | Total Sample Size | Age, Year | Males, N (Y%) | FEV1, % Predicted | Device | Time over which Participants were Instructed to Wear the Device | Minimum Daily wear Time to be Included in Analyses | Minimum Number of Days Data Needed to be Available to be Included in Analyses | Days Used in Data Analyses |
---|---|---|---|---|---|---|---|---|---|
Studies which used a monitor with a thigh inclinometer and a 12 h protocol | |||||||||
Breyer (2010) [24] | 60 | 60 ± 9 | 27 (45) | 46 ± 18 | DAM | 3 days | 12 h | 3 days | Weekend days were excluded |
Cani (2019) [25] |
59 | O2: 68 ± 8 C: 67 ± 8 |
O2: 21 (79) C: Not recorded |
O2: 25 ± 7 C: 24 ± 9 |
DAM | 2 days | 12 h | 2 days | All days included |
Kawagoshi (2013) [41] | 26 | 77 ± 6 | 26 (100) | 53 ± 26 | A-MES | 7 days | 12 h | 2 days | All days included |
Munari (2018) [31] | 115 | 66 ± 8 | 75(68) | 35 ± 16 | DAM | Not reported | 12 h | 2 days | All days included |
Pitta (2005) [12] |
50 | 64 ±7 | 36 (72) | 43 ± 18 | DAM | 2 days | 12 h | 2 days | All days included |
Pitta (2005) [33] |
13 | 61 ±8 | 10 (77) | 33 ± 10 | DAM | 1 day | 12 h | 1 day | All days included |
Pitta (2009) [32] |
80 | A: 63 ± 7 B: 66 ± 8 |
A: 21 (53) B: 18 (45) |
A: 48 ± 17 B: 46 ± 17 |
DAM | 2 days | 12 h | 2 days | All days included |
Probst (2011) [34] | 40 | Ix: 65 ± 10 C: 67 ± 7 |
21 (52) | Ix: 39 ± 14 C: 40 ± 13 |
DAM + SWA | 2 days | 12 h | 2 days | Weekend days were excluded |
Studies that used a monitor without a thigh inclinometer and a 12 h protocol | |||||||||
Furlanetto (2017) [6] | 101 | 66 (62–72) median (IQR) | 58 (57) | 41(30–50) | SWA + Dynaport | 2 days | 12 h | 2 days | Weekend days were excluded |
Gulart (2018) [26] | 59 | 65 ± 9 | 45 (76) | 35 ± 13 | Dynaport minimod | 2 days | 12 h | 2 days | All days included |
Gulart (2020) [27] | 53 | 64 ± 9 | 37 (70) | 38 ± 14 | Dynaport minimod | 2 days | 12 h | 2 days | All days included |
Gulart (2020) [28] | 61 | 65 ± 9 | 47 (77) | 35 ± 13 | Dynaport minimod | 2 days | 12 h | 2 days | All days included |
Karloh (2016) [37] | 38 | 65 ± 7 | 22 (58) | 41 ± 15 | Dynaport minimod | 2 days | 12 h | 2 days | All days included |
Machado (2019) [29] | 270 | G1: 67 ± 8 G2: 67 ± 8 G3: 68 ± 9 C: 67 ± 7 |
G1:25 (74) G2:35 (63) G3:59 (80) C: 33 (31) |
G1: 47 ± 16 G2: 43 ± 16 G3: 42 ± 16 C: 50 ± 14 |
SWA | 2 days | ≥10 h | 2 weekdays | Weekend days were excluded |
Morita (2018) [30] | 145 | 65 (60–73) median (IQR) | 67 (46) | 45 ± 15 | Dynaport move-monitor | 2 days | 12 h | 2 days | All days included |
Schneider (2018) [35] | 137 | 66 ± 8 | 75 (56) | 46 (31–54) IQR | SWA | 2 days | ≥10 h | 2 weekdays | All days included |
Studies that used a monitor without a thigh inclinometer and a waking hours protocol | |||||||||
Alyami (2018) [47] | 34 | 62 ± 5 | 34(100) | 46 ± 16 | SAM | 8 days | ≥10 h | ≥5 days | All days included |
Bernard (2018) [38] | 941 | 57 ± 15 | 519(55) | 85 ± 28 | Actical | 7 days | ≥8 h | ≥4 days | All days included |
Cruz (2014) [45] |
16 | 66 ± 11 | 11(69) | 70 ± 23 | Actigraph | 7 days | ≥8 h | ≥5 days | All days included |
Cruz (2016) [46] |
32 | 67 ± 8 | 27(84) | 67 ± 20 | Actigraph | 4 weekdays | ≥8 h | 4 days | Weekend days were excluded |
Eliason (2011) [48] | 44 | Mild COPD: 64 ± 6 Moderate COPD: 64 ± 8 Severe COPD: 63 ± 8 |
16(36) | Not recorded | Actigraph | 7 days | ≥8 h | ≥3 days | All days included |
Geidl (2019) [39] |
326 | 58 ± 6 | 174 (68) | 54 ± 18 | Actigraph | 7 days | ≥10 h | ≥5 days | All days included |
Larson (2014) [50] | 49 | Ix: 71 ± 8 Ix: 72 ± 9 C: 71 ± 8 |
41(84) | Ix: 61 ± 20 Ix: 54 ± 17 C: 56 ± 17 |
Actigraph | 7 days | ≥10 h | ≥3 days | All days included |
Park (2013) [42] |
224 | 70 ± 9 | 114(51) | Actigraph | 7 days | ≥10 h | ≥4 days | All days included | |
Vasilopoulou (2018) [40] | 147 | Ix: 67 ± 10 Ix: 67 ± 7 C: 64 ± 8 |
Ix: 44(94) Ix: 38(76) C: 37(74) |
Ix: 50 ± 22 Ix: 52 ± 17 C: 52 ± 21 |
Actigraph | Not recorded | ≥8 h | ≥4 days | All days included |
Studies that used a monitor with a thigh inclinometer and 24 h sleep removed protocol | |||||||||
Cheng (2020) [22] | 69 | 74 ± 9 | 33 (48) | 55 ± 15 | ActivPAL | 7 days | ≥10 h | ≥4 days | All days included |
Hill (2020) [11] |
11 | 72 ± 9 | 5 (45) | 28 ± 26 | ActivPAL | 5 to 7 days | ≥10 h | ≥3 days | All days included |
Mesquita (2017) [43] | 90 | 67 ± 8 | 54 (60) | 47 ± 9 | MOX and CAM | ≥7 days | ≥10 h | 5 days | All days included |
Mesquita (2017) [44] | 125 | 67 ± 4 | 69 (55) | 50 ± 9 | MOX | ≥7 days | ≥10 h | 5 days | All days included |
Studies that used a monitor without a thigh inclinometer and a 24 h sleep removed protocol | |||||||||
Holland (2017) [9] | 160 | Ix: 69 ± 13 Ix: 69 ± 10 |
Ix: 48 (60) Ix: 51 (64) |
52 ± 19 49 ± 19 |
SWA | 7 days | ≥10 h | ≥4 days | Yes 1 w/e day included |
Lewis (2016) [6] |
24 | 75 ± 8 | 18(75) | 54 ± 23 | SWA + Actigraph | 7 days | ≥12 h | 6 days | All days included |
Loprinzi (2015) [51] | 10 | 70 ± 10 | 4(40) | 68 ± 48 | Actigraph | 7 days | ≥10 h | 4 days | All days included |
McNamara (2014) [23] | 50 | COPD + PC: 73 ± 11 COPD: 70 ± 8 |
COPD + PC: 11 (44) COPD: 12 (48) |
51 ± 17 54 ± 11 |
SWA | 9 days | >85% wear time | 3 days | All days included |
Orme (2019) [49] |
109 | 66 ± 7 | 67 (61) | 76 ± 18 | Actigraph | 7 days | ≥10 h | ≥4 days | All days included |
Schneider (2018) [36] | 45 | 66 ± 8 | 25 (55) | 46 ± 20 | SWA | 7 days | 24 h (3 groups: 8 h; 12 h; period awake) |
7 days | All days included |
Wootton (2017) [10] | 101 | Ix: 69 ± 8 C: 68 ± 9 |
Ix: 38(61) C: 24(62) |
Ix: 42 ± 15 C: 43 ± 15 |
SWA | 7 days | ≥12 h | ≥3 days primary analysis ≥4 days secondary analysis |
No (primary analysis); 1 w/e day included (secondary analysis) |
Data are mean ± SD unless otherwise stated, A-MES: Activity Monitor and Evaluation System; C: control group; CAM: CIRO Activity Monitor; COPD + PC: chronic obstructive pulmonary disease + physical comorbidity; DAM: DynaPort Activity Monitor; FEV1% pred: forced expiratory volume in 1 s expressed as a percent predicted; Ix: intervention group; MOX: Mobile Only Accelerometer; O2: oxygen; SAM: Stepwatch Activity Monitor; SWA: SenseWear Armband.